Grifols reviews

Low salary, poor benefits, awful working conditions, incompetent management. To make it worse, Talecris was a pretty good employer. They were good to employees, made lots of money for investors, and provided life-saving drugs to patients in need. Now everything is about feeding the CEO's very oversized ego. It's understandable that after buying Talecris, they would need to be tight with money, but how can they justify laying off people and slashing R&D spending and then build a museum (as if anyone actually is actually going to visit an industrial plasma fractionation museum) and the CEO doesn't have time to run the company but has time to write memoirs.

Decisions are made in Spain, often without consulting with executives or managers in the USA. This results in chaos and eventual backpedaling when decisions are announced. The company does NOT treat its USA employees with respect. At the same time as the global CEO was touting how the company had increased salaries (presumably in Spain, although that was not stated), compensation for between a third and a half of the USA workforce was cut, mostly through reductions to bonus targets and eliminating company paid short term disability. As the company continues to trim some parts of its workforce after the acquisition of Talecris, they are circumventing the severance plan and instead dismissing uneeded people by making up performance issues and terminating for cause (hard to know the extent of this, but I know of several cases where long-term, well respected employees were pushed out in this manner). In some parts of the company, not surprisingly, stress levels are very high, and morale poor. Some people have had health issues related to stress.